Developing, funding and conducting clinical trials in immune tolerance

DARE-APS | A clinical trial for individuals with Antiphospholipid Syndrome (APS)

Living with Antiphospholipid Syndrome?

DARE-APS may be an option for you.

The DARE-APS Study

A study about the safety of daratumumab in patients with antiphospholipid syndrome (APS), and its effectiveness at reducing the antiphospholipid antibodies that cause APS.

 

Learn more ›

Am I Eligible?

If you are 18-70 and have a history of APS, you may be eligible.

 

Learn more ›

Study Locations

DARE-APS will be conducted at multiple locations across the United States.

 

Learn more ›